Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
SAGE documentation
2020
2017
Clear all
Type of publications
NITAG documentation
(103)
SAGE documentation
(12)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(171)
Topics
Evidence to recommendation table
(3)
GRADE table
(6)
Position paper
(2)
SAGE background document
(1)
Regions
Countries
Diseases
COVID-19
(2)
Human papillomavirus (HPV)
(10)
Cholera
(2)
Dengue
(1)
Diphtheria
(3)
Hepatitis B
(3)
Influenza
(1)
Measles
(10)
Pneumococcal disease
(3)
Poliomyelitis
(1)
Rabies
(3)
Rubella
(4)
Tetanus
(1)
Typhoid
(4)
Yellow fever
(1)
Publication date
2020
(2)
2017
(10)
2023
(2)
2022
(18)
2021
(4)
2018
(1)
2015
(2)
2014
(2)
2008
(1)
Target population
Available to download in languages
English (EN)
(12)
French (FR)
(1)
12 results found
2020
∙
WHO, SAGE
Infographic of the SAGE roadmap for prioritizing uses Of COVID-19 vaccines in the context of limited supply
2020
∙
SAGE
WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination
2017
∙
SAGE
Efficacy of 2 vs. 3 doses of HPV vaccination in immunocompetent girls
2017
∙
SAGE
Efficacy of HPV vaccination in HIV infected girls
2017
∙
SAGE
Efficacy of' HPV vaccination in adolescent girls
2017
∙
SAGE
Human papillomavirus vaccines: WHO position paper
2017
∙
SAGE
Immunogenicity of 2 vs. 3 doses of HPV vaccination in immunocompetent girls
2017
∙
SAGE
In 9 to 15-year old females, is 9-valent human papillomavirus vaccine (HPV) vaccine superior to 4-valent or 2-valent HPV vaccines?
2017
∙
SAGE
Protection of anogenital warts conferred by HPV vaccination in immunocompetent girls
2017
∙
SAGE
Safety of HPV vaccination in HIV infected girls
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register